Wan-Qin Chong

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

National University Cancer Institute, Singapore(Current)

National University of Singapore

National University Health System

Tan Tock Seng Hospital

National Cancer Centre Singapore

Wan-Qin Chong is an author at National University Cancer Institute, Singapore specializing in oncology, cancer treatment planning, and toxicity management.

Publications per year

2020–2025

Publications

Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia

Jia Li Low, Elaine Hsuen Lim, Lavina Bharwani et al. · Therapeutic Advances in Medical Oncology · 2022 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial

Wan-Qin Chong, Jia-Li Low, Joshua K. Tay et al. · The Lancet Oncology · 2025 · 17 citations

Medicine, Oncology, Pharmacotherapy +12

Use of decision aid to improve informed decision-making and communication with physicians on the use of oral complementary and alternative medicine (CAM) among cancer patients on chemotherapy treatment: a randomised controlled trial

Wan-Qin Chong, Maria Jannet Mogro, Asrie Arsad et al. · Supportive Care in Cancer · 2020 · 10 citations

Medicine, Oncology, Chemotherapy +16

1–3 of 3